Literature DB >> 9059313

Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide.

D E Newby1, N A Boon, D J Webb.   

Abstract

1. Forearm blood flow responses to incremental challenges of acetylcholine and substance P, administered via the brachial artery, were measured by venous occlusion plethysmography in eight subjects in the presence of saline, the nitric oxide synthase inhibitor, NG-monomethyl-L-arginine, and a control vasoconstrictor, noradrenaline. 2. Substance P and acetylcholine caused dosedependent increases in forearm blood flow (P < 0.001). When separated by 30 min saline infusions, repeated responses did not undergo tachyphylaxis. 3. Noradrenaline caused a mean reduction in basal blood flow of 34-51% (P < 0.001), and augmented the percentage increases in blood flow with both substance P (P = 0.05) and acetylcholine (P = 0.03) infusions. 4. NG-Monomethyl-L-arginine caused a mean reduction in basal blood flow of 42-45% (P < 0.001) and significantly inhibited the responses to both substance P (P < 0.001) and acetylcholine (P = 0.05). 5. In comparison with saline responses, NG-monomethyl-L-arginine caused a mean inhibition of 69 +/- 8% for substance P-induced vasodilatation and 40 +/- 5% for acetylcholine-induced vasodilatation. However, comparing responses with those to the control vasoconstrictor noradrenaline, NG-monomethyl-L-arginine caused a mean inhibition of 81 +/- 5% for substance P responses and 58 +/- 3% for acetylcholine responses. Inhibition by NG-monomethyl-L-arginine of the response to substance P was significantly greater than inhibition of the response to acetylcholine (P = 0.02). 6. Hence, in healthy men, a greater proportion of the forearm vasodilatation to substance P than to acetylcholine appears to be nitric oxide-mediated. Given its greater stability, substance P may be more suitable as a pharmacological tool in the investigation of stimulated nitric oxide production and endothelial cell function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059313     DOI: 10.1042/cs0920133

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

2.  Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature.

Authors:  M Dawes; P J Chowienczyk; J M Ritter
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

3.  Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP).

Authors:  I B Wilkinson; C M McEniery; K H Bongaerts; H MacCallum; D J Webb; J R Cockcroft
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

4.  Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans.

Authors:  William G Schrage; Brad W Wilkins; Christopher P Johnson; John H Eisenach; Jacqueline K Limberg; Niki M Dietz; Timothy B Curry; Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2010-06-17

5.  Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man.

Authors:  D E Newby; D G Sciberras; C J Ferro; B J Gertz; D Sommerville; A Majumdar; R C Lowry; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

6.  Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists.

Authors:  Gary P Van Guilder; Brian L Stauffer; Jared J Greiner; Christopher A Desouza
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-02-15       Impact factor: 4.733

7.  Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans.

Authors:  Christopher A DeSouza; Christopher M Clevenger; Jared J Greiner; Derek T Smith; Greta L Hoetzer; Linda F Shapiro; Brian L Stauffer
Journal:  J Physiol       Date:  2002-07-01       Impact factor: 5.182

Review 8.  Effect of exercise training on endothelium-derived nitric oxide function in humans.

Authors:  Daniel J Green; Andrew Maiorana; Gerry O'Driscoll; Roger Taylor
Journal:  J Physiol       Date:  2004-09-16       Impact factor: 5.182

9.  Exercise prevents age-related decline in nitric-oxide-mediated vasodilator function in cutaneous microvessels.

Authors:  Mark A Black; Daniel J Green; N Timothy Cable
Journal:  J Physiol       Date:  2008-05-15       Impact factor: 5.182

10.  The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Aamer Sandoo; Douglas Carroll; George S Metsios; George D Kitas; Jet J C S Veldhuijzen van Zanten
Journal:  Arthritis Res Ther       Date:  2011-06-21       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.